首頁 > 市場調查報告書 > 製藥

以基因為基之藥物開發

細胞株市場規模、佔有率和成長分析：按類型、細胞株類型、應用、來源、最終用戶和地區分類－2026-2033年產業預測

市場調查報告書

商品編碼

2091943

細胞株市場規模、佔有率和成長分析：按類型、細胞株類型、應用、來源、最終用戶和地區分類－2026-2033年產業預測

Cell Lines market Size, Share, and Growth Analysis, By Type, By Cell Line Type, By Application, By Source, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年07月03日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球細胞株市場價值為 72 億美元，預計到 2025 年將成長至 79.8 億美元，到 2033 年將成長至 181.2 億美元，在預測期（2026-2033 年）內複合年成長率為 10.8%。

全球細胞株市場正經歷顯著成長，這主要得益於監管機構要求減少動物試驗，並推動安全性評估轉向基於細胞的檢測方法。這導致對能夠更真實地模擬人體生理功能的疾病特異性客製化細胞株的需求不斷成長。諸如「晶片器官」平台等創新技術，利用患者來源的細胞株進行心臟毒性篩檢等應用，正吸引生物技術產業內眾多重要的合作項目。同時，人工智慧驅動的自動化正在革新工作流程，加速克隆篩選並最佳化流程。這最大限度地減少了人為錯誤，並縮短了研發週期。機器學習和機器人技術的整合不僅提高了效率和產品一致性，還使製造商能夠在滿足日益成長的生物製藥需求的同時，保持嚴格的品質標準和成本效益。

全球細胞株市場的成長要素

生物製藥需求的不斷成長，催生了對能夠支持大規模蛋白質生產的可靠細胞株平台的迫切需求，這對全球細胞株市場產生了顯著影響。這一趨勢促使製藥公司加大對細胞株開發和許可的投資。隨著生物製藥療法在治療方案中的重要性日益凸顯，生產商渴望使用能夠保證高產量、穩定性和符合監管標準的細胞株，從而為成熟和新興的細胞株供應商創造了不斷擴大的市場。對療效和市場擴張的關注，推動了該領域研究、夥伴關係和基礎設施的持續發展。

全球細胞株市場的限制因素

全球細胞株市場面臨許多挑戰，主要原因是不同地區對不同細胞株的使用有不同的法規結構。這導致產品需要進行大量的文件記錄、驗證和合規性測試才能獲得臨床和商業用途的批准。適應各種安全標準、生物安全分類和倫理指南，使得研發過程複雜化，導致研發週期延長和資源消耗過高。這種複雜性阻礙了新進入者，抑制了創新細胞株的快速應用，並最終限制了市場成長。此外，持續的合規要求增加了營運成本，限制了中小企業的投資機會。

全球細胞株市場趨勢

隨著生物製藥公司優先開發針對個別患者特徵的客製化療法，全球細胞株市場正經歷著向個人化醫療的顯著轉變。這種趨勢推動了對能夠真實反映不同遺傳背景的細胞株的需求成長，促使學術機構與專業生物技術公司加強合作，建立全面的供體來源細胞株庫。這些進展提高了臨床前試驗的準確性，並促進了製造商客製化服務的擴展。因此，細胞株平台在包括腫瘤學、罕見疾病和免疫療法在內的多個治療領域的應用正在加速，並逐漸成為創新藥物發現和開發策略的關鍵要素。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭資訊

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
企業市場占有率分析，2025 年
主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）

主要公司簡介

Thermo Fisher Scientific Inc.
Merck KGaA
Danaher Corporation
Sartorius AG
Lonza Group AG
FUJIFILM Holdings Corporation
Charles River Laboratories International, Inc.
Corning Incorporated
Agilent Technologies, Inc.
Bio-Techne Corporation
Revvity, Inc.
Creative Bioarray
PromoCell GmbH
Cell Biologics, Inc.
ATCC
European Collection of Authenticated Cell Cultures（ECACC）
DSMZ GmbH
WuXi AppTec Co., Ltd.
GenScript Biotech Corporation
Creative Biolabs

結論與建議

簡介目錄

Product Code: SQMIG35H2638

Global Cell Lines Market size was valued at USD 7.2 Billion in 2024 and is poised to grow from USD 7.98 Billion in 2025 to USD 18.12 Billion by 2033, growing at a CAGR of 10.8% during the forecast period (2026-2033).

The global cell lines market is experiencing significant growth driven primarily by regulatory pressures to reduce animal testing, prompting a shift towards cell-based assays for safety evaluations. This has led to an increased demand for customized, disease-specific cell lines that better mimic human physiology. Innovations such as organ-on-chip platforms, which utilize patient-derived lines for applications like cardiotoxicity screening, are attracting noteworthy collaborations within the biotech sector. Simultaneously, AI-driven automation is revolutionizing workflows by expediting clone selection and optimizing processes, minimizing human error, and shortening development cycles. This integration of machine learning and robotics not only enhances efficiency and product consistency but also positions manufacturers to meet rising biologics demand while adhering to stringent quality standards and cost-effectiveness.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Lines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Lines Market Segments Analysis

Global cell lines market is segmented by type, cell line type, application, source, end user and region. Based on type, the market is segmented into Finite Cell Lines and Continuous Cell Lines. Based on cell line type, the market is segmented into Mammalian Cell Lines, Insect Cell Lines, Microbial Cell Lines and Others. Based on application, the market is segmented into Biopharmaceutical Production, Drug Discovery & Development, Toxicity Testing, Tissue Engineering & Regenerative Medicine, Research Applications and Others. Based on source, the market is segmented into Human Cell Lines and Animal Cell Lines. Based on end user, the market is segmented into Biopharmaceutical Companies, Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Lines Market

The increasing demand for biologics is significantly influencing the Global Cell Lines market by generating a strong need for dependable cell line platforms capable of supporting large-scale protein production. This trend prompts pharmaceutical companies to invest substantially in the development and licensing of cell lines. As biologic therapies gain prominence in treatment protocols, manufacturers are keen to utilize cell lines that ensure high yield, stability, and adherence to regulatory standards, thus broadening the market for both established and emerging cell line providers. This emphasis on therapeutic effectiveness and market expansion drives continuous research, partnerships, and infrastructure growth within the sector.

Restraints in the Global Cell Lines Market

The Global Cell Lines market faces significant challenges due to the diverse regulatory frameworks that govern cell line usage across different regions. This requires companies to engage in extensive documentation, validation, and compliance testing for products to gain approval for clinical and commercial applications. Navigating varying safety standards, biosafety classifications, and ethical guidelines complicates the development process, resulting in longer timelines and higher resource expenditures. This complexity can deter new entrants and hinder the rapid adoption of innovative cell lines, ultimately restraining market growth. Additionally, the continual need for compliance raises operational costs, restricting the investment potential for smaller companies.

Market Trends of the Global Cell Lines Market

The Global Cell Lines market is witnessing a significant trend towards personalized medicine, as biopharma companies emphasize the development of therapies tailored to individual patient profiles. This focus drives the demand for cell lines that authentically represent diverse genetic backgrounds, resulting in increased collaborations with academic institutions and specialized biotech firms to create extensive panels of donor-derived lines. Such advancements enhance the accuracy of preclinical testing and foster the expansion of customization services by manufacturers. The market consequently sees accelerated adoption across various therapeutic areas, including oncology, rare diseases, and immunotherapy, establishing cell line platforms as essential components of innovative drug discovery and development strategies.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape
Disease Epidemiology
Pipeline Analysis

Global Cell Lines market Size by Type & CAGR (2026-2033)

Market Overview
Finite Cell Lines
Continuous Cell Lines

Global Cell Lines market Size by Cell Line Type & CAGR (2026-2033)

Market Overview
Mammalian Cell Lines
Insect Cell Lines
Microbial Cell Lines
Others

Global Cell Lines market Size by Application & CAGR (2026-2033)

Market Overview
Biopharmaceutical Production
Drug Discovery & Development
Toxicity Testing
Tissue Engineering & Regenerative Medicine
Research Applications
Others

Global Cell Lines market Size by Source & CAGR (2026-2033)

Market Overview
Human Cell Lines
Animal Cell Lines

Global Cell Lines market Size by End User & CAGR (2026-2033)

Market Overview
Biopharmaceutical Companies
Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Others

Global Cell Lines market Size & CAGR (2026-2033)

North America (Type, Cell Line Type, Application, Source, End User)
- US
- Canada
Europe (Type, Cell Line Type, Application, Source, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Cell Line Type, Application, Source, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Cell Line Type, Application, Source, End User)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Cell Line Type, Application, Source, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Holdings Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Charles River Laboratories International, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Bioarray
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Biologics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATCC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
European Collection of Authenticated Cell Cultures (ECACC)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSMZ GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi AppTec Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biolabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments